ARESTIN Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Arestin, and what generic alternatives are available?

Arestin is a drug marketed by Orapharma and is included in one NDA.

The generic ingredient in ARESTIN is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Arestin

A generic version of ARESTIN was approved as minocycline hydrochloride by WATSON LABS on December 30^th, 1991.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ARESTIN?
What are the global sales for ARESTIN?
What is Average Wholesale Price for ARESTIN?

Summary for ARESTIN

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	95
Clinical Trials:	7
Patent Applications:	2,826
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for ARESTIN
What excipients (inactive ingredients) are in ARESTIN?	ARESTIN excipients list
DailyMed Link:	ARESTIN at DailyMed

Drug patent expirations by year for ARESTIN

Recent Clinical Trials for ARESTIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Minnesota	Phase 4
Bausch Health Companies, INC.	Phase 4
University of Minnesota - Clinical and Translational Science Institute	Phase 4

See all ARESTIN clinical trials

Pharmacology for ARESTIN

Drug Class	Tetracycline-class Drug
Physiological Effect	Decreased Prothrombin Activity

US Patents and Regulatory Information for ARESTIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Orapharma	ARESTIN	minocycline hydrochloride	POWDER, EXTENDED RELEASE;DENTAL	050781-001	Feb 16, 2001		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ARESTIN

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Orapharma	ARESTIN	minocycline hydrochloride	POWDER, EXTENDED RELEASE;DENTAL	050781-001	Feb 16, 2001	⤷ Sign Up	⤷ Sign Up
Orapharma	ARESTIN	minocycline hydrochloride	POWDER, EXTENDED RELEASE;DENTAL	050781-001	Feb 16, 2001	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ARESTIN

See the table below for patents covering ARESTIN around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Australia	2003223384	DISPENSING APPARATUS AND CARTRIDGE	⤷ Sign Up
Portugal	2263596		⤷ Sign Up
Colombia	5611079	APARATO DISPENSADOR Y CAPSULA	⤷ Sign Up
Brazil	0308859	Aparelho de distribuição e cartucho	⤷ Sign Up
Slovenia	2263596		⤷ Sign Up
Canada	2479995	DISTRIBUTEUR ET CARTOUCHE (DISPENSING APPARATUS AND CARTRIDGE)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for ARESTIN

Recent Clinical Trials for ARESTIN

Pharmacology for ARESTIN

Make Better Decisions: Try a trial or see plans & pricing